Abstract
Objective
This case–control study aimed to identify the risk factors of nontraumatic necrosis of the femoral head (NONFH).
Methods
In all, 242 patients with NONFH treated at the hip disease research center of our hospital between March 2012 and October 2015 were included. After excluding 19 patients with tumor or tuberculosis, 223 patients were enrolled. Controls comprised 223 healthy persons selected from our hospital database. Single-factor variance analysis and t test were performed to select the index of statistical significance. The 95% confidence interval (95% CI) and normal range of the selected indicators were compared, and abnormal related indexes were selected from the femoral head necrosis group. The selected indicators were based on the increase or decrease to locate the risk indicators and render their corresponding assignment. Logistic regression analysis of the risk factors was performed after the assignment.
Results
The necrotic group of patients with decreased carbon dioxide combining power (CO2CP), increased total cholesterol, increased low-density lipoprotein, and decreased high-density lipoprotein levels had statistically significant partial regression coefficient values and the odds ratios were 73.5 (95% CI 24.59–219.74), 7.15 (3.51–14.85), 633.07 (121.7–3304.78), and 20.11 (9.36–43.8), respectively, indicating that these are strong risk factors for NONFH.
Conclusions
Abnormal lipid metabolism is a strong risk factor of NONFH. Lipid examination can be used as a screening tool for NONFH in high-risk populations, for alcoholism, and many hormone applications. The decreased CO2CP was associated with NONFH, and bone microcirculation was considered to possibly lead various conditions such as ischemia and hypoxia-related bone metabolic acidosis. However, further study is needed.
Zusammenfassung
Ziel
Das Ziel dieser Fall-Kontroll-Studie ist es, die Risikofaktoren für eine nichttraumatische Hüftkopfnekrose (NONFH) zu identifizieren.
Methoden
In die Studie wurden insgesamt 242 Patienten mit NONFH eingeschlossen, die am Behandlungszentrum für Hüfterkrankungen in unserer Klinik zwischen März 2012 und Oktober 2015 behandelt wurden. Nach Ausschluss von 19 Patienten mit Tumoren oder Tuberkulose nahmen 223 Patienten an der Studie teil. Die Kontrollgruppe bestand aus 223 gesunden Personen, die aus unserer Klinikdatenbank ausgewählt wurden. Eine einfaktorielle Varianzanalyse sowie ein t‑Test wurden durchgeführt, um den Index für die statistische Signifikanz zu wählen. Das 95% Konfidenzintervall (95% CI) und die normale Spannweite der ausgewählten Indikatoren wurden verglichen, und abnormale Indices wurden aus der Hüftkopfnekrose-Gruppe selektiert. Die selektierten Indikatoren basierten auf der Erhöhung oder Verminderung, um die Risikofaktoren zu finden und diese mit der jeweiligen Zuordnung in Beziehung zu setzen. Nach der Zuordnung wurde eine logistische Regressionsanalyse der Risikofaktoren durchgeführt.
Ergebnisse
Die nekrotische Patientengruppe mit erniedrigten CO2CP-Werten („carbon dioxide combining power“), erhöhten Gesamt-Cholesterinwerten, erhöhtem Lipoprotein mit geringer Dichte („low-density lipoprotein“, LDL) und erniedrigtem Lipoprotein mit hoher Dichte („high-density lipoprotein“, HDL) hatte statistisch signifikante partielle Regressionskoeffizienzwerte, wobei die Odds-Ratios 73,5 (95% CI 24,59–219,74), 7,15 (3,51–14,85), 633,07 (121,7–3304,78) bzw. 20,11 (9,36–43,8) betrugen, was darauf hinweist, dass diese Werte große Risikofaktoren für eine NONFH darstellen.
Schlussfolgerung
Ein abnormaler Lipidstoffwechsel ist ein großer Risikofaktor für eine NONFH. Eine Lipiduntersuchung kann als Screeningmethode für eine NONFH in Hochrisikopopulationen, bei Alkoholismus und vielen hormonellen Anwendungen verwendet werden. Der erniedrigte CO2CP-Wert war mit einer NONFH assoziiert, und die Knochenmikrozirkulation könnte zu unterschiedlichen Erkrankungen, wie einer Ischämie und einer hypoxiebedingten metabolischen Azidose, führen. Hierzu sind jedoch weitere Studien nötig.
Similar content being viewed by others
References
Zhang Y, Liu Y, Zhou G, Chen Z, He W, Zhou C, Wang H, Chen X (2015) Fibular allograft for osteonecrosis prevention in the management of femoral neck fractures: clinical outcome and biomechanical evaluation. J Biomater Tiss Eng 5(12):937–941
Win AZ, Aparici CM (2015) Non-traumatic radiation-induced avascular necrosis of the femoral neck. QJM 108(3):257–258
Tong PJ, Ye FS, Zhang SX, Li J, Xin-Qi L (2014) Treatment of non-traumatic femoral head avascular necrosis by perfusion of bone marrow stromal stem cells through optional artery. Zhongguo Gu Shang 27(7):565–569
Zhou G, Zhang Y, Zeng L, He W, Pang Z, Chen X, Xu Y, Stephen LS, Chen L (2015) Should thorough debridement be used in fibular allograft with impaction bone grafting to treat femoral head necrosis: a biomechanical evaluation. BMC Musculoskelet Disord 16(1):140
Mont MA, Jones LC, Hungerford DS (2006) NONFH : ten years later. J Bone Joint Surg Am 88(5):1117–1132
Di Benedetto P, Niccoli G, Beltrame A, Gisonni R, Cainero V, Causero A (2016) Histopathological aspects and staging systems in non-traumatic femoral head osteonecrosis: an overview of the literature. Acta Biomed 87(Suppl 1):15–24
Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P (2016) Osteonecrosis of the jaw in patients receiving bone-targeted therapies: an overview – part I. Urol Nurs 36(3):111–116 (154)
Kawai K, Tamaki A, Hirohata K (1985) Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. J Bone Joint Surg Am 67(5):755–763
Gomez-Mont LJ, Gil-Orbezo F, Morales-Dominguez H, Navarrete-Alvarez M, Trueba-Davalillo C, Capuano-Tripp P (2015) Nontraumatic causes of bilateral avascular ONFH: link between hepatitis C and pegylated interferon. Acta Ortop Mex 29(3):172–175
Liu B, Sun W, Li Z, Yue D, Zhang Z, Chen D, Wang X (2010) Study on correlation between single nucleotide polymorphism in promotor of hepatic lipase gene and nontraumatic avascular necrosis of femoral head. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(12):1444–1448
Karatoprak O, Korkmaz MF, Kara AN, Gogus A, Isiklar ZU (2008) Early results of autologous mononuclear bone marrow cell implantation in nontraumatic avascular ONFH. Acta Orthop Traumatol Turc 42(3):178–183
Rupp RE, Rupp SN (2016) Femoral head avascular necrosis is not caused by arthroscopic posterolateral femoroplasty. Orthopedics 39(3):177–180
Tan G, Kang PD, Pei FX (2012) Glucocorticoids affect the metabolism of bone marrow stromal cells and lead to ONFH: a review. Chin Med J (Engl) 125(1):134–139
Kerachian MA, Seguin C, Harvey EJ (2009) Glucocorticoids in ONFH: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114(3–5):121–128
Handal JA, John TK, Goldstein DT, Khurana JS, Saing M, Braitman LE, Samuel SP (2012) Effect of atorvastatin on the cortical bones of corticosteroid treated rabbits. J Orthop Res 30(6):872–876
Sekiya F, Yamaji K, Yang K, Tsuda H, Takasaki Y (2010) Investigation of occurrence of ONFH after increasing corticosteroids in patients with recurring systemic lupus erythematosus. Rheumatol Int 30(12):1587–1593
Chernetsky SG, Mont MA, LaPorte DM, Jones LC, Hungerford DS, McCarthy EF (1999) Pathologic features in steroid and nonsteroid associated osteonecrosis. Clin Orthop Relat Res 368:149–161. doi:10.1097/00003086-199911000-00018
Suh KT, Kim SW, Roh HL, Youn MS, Jung JS (2005) Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res:. doi:10.1097/01.blo.0000150568.16133.3c
Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T (2007) ONFH: etiology, imaging and treatment. Eur J Radiol 63(1):16–28
Funding
This study was supported by the National Science Foundation of China (81473704) and the Science and Technology Project of Henan Province (162102310364). None of the authors of this paper have any financial and personal relationships with other people or organizations that could inappropriately influence the work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Y. Zhang, R. Sun, L. Zhang, L. Feng, and Y. Liu declare that they have no competing interests.
This study was approved by the regional ethics committee of our hospital, and all the patients signed informed consent forms. Informed consent was obtained from all individual participants included in the study.
Additional information
Ying Zhang and Ruibo Sun contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, Y., Sun, R., Zhang, L. et al. Effect of blood biochemical factors on nontraumatic necrosis of the femoral head. Orthopäde 46, 737–743 (2017). https://doi.org/10.1007/s00132-017-3408-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00132-017-3408-4
Keywords
- Carbon dioxide combining power
- Total cholesterol
- High-density lipoproteins
- Low-density lipoproteins
- Lipid metabolism disorders